Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

The Efficacy and Safety of Levocetirizine Dihydrochloride Oral Drops Given 0.125 mg/kg b.i.d. During 90 Days in the Treatment of Recurrent Cough Associated With Other Allergic Symptoms, e.g. Wheezing, in Children Aged 1-2 Years.

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Inclusion Criteria:

• infants from 2 to 24 months both inclusive
• suffering from recurrent cough associated with other allergic symptoms
• hospitalized for respiratory or allergy related problems
• laboratory results within normal ranges
• height and weight between percentile 5 and 95

Exclusion Criteria:

• having taken any of the disallowed medication
• suffering form any disorder
• history of sleep apnea
• having concomitant chronic disease
• known relevant renal, hepatic, cardiac or metabolism dysfunction
• known alcohol or drug addiction, severe psychiatric disease for the parent/guardian